Improve Research Reproducibility A Bio-protocol resource
Concise Method
tooltip

2.2. Patients

PG Philippe Gautret
JL Jean-Christophe Lagier
PP Philippe Parola
VH Van Thuan Hoang
LM Line Meddeb
MM Morgane Mailhe
BD Barbara Doudier
JC Johan Courjon
VG Valérie Giordanengo
VV Vera Esteves Vieira
HD Hervé Tissot Dupont
SH Stéphane Honoré
PC Philippe Colson
EC Eric Chabrière
BS Bernard La Scola
JR Jean-Marc Rolain
PB Philippe Brouqui
DR Didier Raoult
ask Ask a question
Favorite

Hospitalized patients with confirmed COVID-19 were included in this study if they fulfilled two primary criteria: i) age >12 years; ii) PCR documented SARS-CoV-2 carriage in nasopharyngeal sample at admission whatever their clinical status.

Patients were excluded if they had a known allergy to hydroxychloroquine or chloroquine or had another known contraindication to treatment with the study drug, including retinopathy, G6PD deficiency and QT prolongation. Breastfeeding and pregnant patients were excluded based on their declaration and pregnancy test results when required.

Copyright and License information:  ©2020 Published by Elsevier B.V.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A